10-74112029-A-G
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014000.3(VCL):c.2866A>G(p.Met956Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000253 in 1,461,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M956R) has been classified as Uncertain significance.
Frequency
Consequence
NM_014000.3 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathy 1WInheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- dilated cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathy 15Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.00000398  AC: 1AN: 251454 AF XY:  0.00000736   show subpopulations 
GnomAD4 exome  AF:  0.0000253  AC: 37AN: 1461894Hom.:  0  Cov.: 35 AF XY:  0.0000303  AC XY: 22AN XY: 727248 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1W    Uncertain:1 
ClinVar contains an entry for this variant (Variation ID: 408953). This variant has not been reported in the literature in individuals affected with VCL-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 956 of the VCL protein (p.Met956Val). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Dilated cardiomyopathy 1W;C2750459:Hypertrophic cardiomyopathy 15    Uncertain:1 
- -
Cardiovascular phenotype    Uncertain:1 
The p.M956V variant (also known as c.2866A>G), located in coding exon 19 of the VCL gene, results from an A to G substitution at nucleotide position 2866. The methionine at codon 956 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at